GEN Exclusives

More »

Corporate Profiles

More »
Nov 1, 2010 (Vol. 30, No. 19)

Animal-Free Toxicity Testing and Drug Screening

Epithelix Develops Artificial Tissues that Model the Lining of the Airway and Lungs

  • Click Image To Enlarge +
    MucilAir™ is sold in a 6.5 mm diameter Corning Transwell with a pore size of 0.4 µm. Each reconstituted epithelium contains about 400,000 cells.

    While a graduate student at the University of Geneva, Switzerland, Ludovic Wiszniewski, Ph.D., teamed up with three colleagues to optimize a technology platform discovered there. In March 2006, they launched Epithelix Sarl, a company that specializes in tissue engineering. Epithelix develops, produces, and sells reconstituted in vitro human airway tissues for toxicity testing of chemicals and the study of human diseases. Its products also help to reduce the need for expensive animal testing.

    Other companies are developing substitutes for animal toxicity tests based largely on liver cells. Epithelix, instead, is developing artificial tissues that model the lining of the airways and lungs. “Our initial focus was on airway tissues because we have special expertise in reconstituting these kinds of tissues,” says Samuel Constant, Ph.D., COO. “Back then, a good in vitro model for airways didn’t exist.”

    Epithelix’ core product is MucilAir, a 3-D model of the human airway epithelium made up of primary human cells isolated from the nasal cavity, trachea, and bronchus. Once differentiated, MucilAir mimics the morphology and function of the native human airway epithelia, including beating cilia, active ion transport, and tight junctions. Each culture contains three principal primary cell types—basal, goblets, and ciliated cells. The mucocilliary clearance is fully functional.

    “These tissue cultures are as close as possible to the in vivo situation, and they contain no transformed cells,” Dr. Constant says. What’s more, the tissue remains fully differentiated and functional for more than a year.

    MucilAir is available in 24-well plates for early screening. Epithelix also sells chemically defined culture media for growing MucilAir and other tissue cultures. “The culture media is the best way to grow tissues and it’s important for a long shelf life,” adds Dr. Constant. All tissue cultures are performance-assayed and test negative for HIV-1, mycoplasma, hepatitis B, hepatitis C, bacteria, yeast, and fungi.

    Since MucilAir has a similar microanatomy to that of natural respiratory tract tissue, it responds in the same way to various chemicals. Its ability to stay active for up to one year makes MucilAir ideal for long-term toxicity testing of environmental chemicals, including airborne toxicants, nanoparticles, and ingredients in perfumes, cosmetics, and household products. The company’s technology is the only one that can monitor the chronic effects of environmental toxicants or drug candidates, according to Dr. Constant. Many toxicants, such as components in cigarettes, do not produce immediate tissue damage but require repetitive doses to inflict injury.

    Another application for the airway tissue cultures is to evaluate the performance of drugs or drug candidates designed to treat specific respiratory diseases such as asthma, COPD, and cystic fibrosis. Different products created by Epithelix consist of tissues derived from primary human cells obtained from healthy people, smokers, and patients with asthma, allergies, COPD, and cystic fibrosis.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?